Omeza Combination Therapy for the Management and Treatment of Chronic Cutaneous Wounds/Ulcers of Multiple Etiologies

Non-healing Wound Clinical Trial

Official title: A Clinical Study to Evaluate the Omeza Combination Therapy for the Management and Treatment of Chronic Cutaneous Wounds/Ulcers of Multiple Etiologies

Status Completed

Clinical Trial Summary

The goal of this clinical trial is to evaluate the use of Omeza combination therapy with Standard of Care. The main question it aims to answer is:

• Can Omeza combination therapy with Standard of Care enable chronic wounds to begin a healing trajectory in a 4-week period?

Patients will be treated with:

• OCM™ Wound Matrix

• Omeza combination therapy

• Standard of Care

Clinical Trial Description

The goal of this clinical trial is to demonstrate that the Omeza combination therapy with Standard of Care supports chronic wounds to move from chronicity to a healing trajectory. The trial is targeting those wounds that have failed therapy prior to trial enrollment and are chronic by definition of no change in area size after 2 weeks of standard of care treatment. The inclusion and exclusion criteria applied to this chronic wound clinical trial is broadened with the intention to include all patients and outliers that would not qualify for controlled trials. ;

Related Conditions & MeSH terms

• Non-Healing Ulcer of Skin
• Non-healing Wound
• Ulcer
• Wounds and Injuries

• NCT number: NCT05921292
• Study type: Interventional
• Source: Omeza, LLC
• Status: Completed
• Phase: Early Phase 1
• Start date: July 11, 2022
• Completion date: May 31, 2024